Pacific Biosciences of Ca... (PACB)

NASDAQ: PACB · Real-Time Price · USD

1.11

0.00 (0.00%)

At close: May 01, 2025, 1:17 PM

Pacific Biosciences of California Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	154.01M	200.52M	128.3M	130.51M	78.89M	90.89M	78.63M	93.47M	90.71M
Cost of Revenue	116.73M	147.74M	79.27M	71.65M	46.33M	56.31M	53.53M	58.81M	46.55M
Gross Profit	37.28M	52.78M	49.03M	58.86M	32.57M	34.58M	25.1M	34.66M	44.16M
Operating Income	-356.38M	-334.47M	-304.82M	-178.16M	-104.39M	-100.55M	-100.99M	-89.78M	-71.24M
Interest Income	n/a	n/a	14.69M	12.53M	267K	2.61M	n/a	n/a	n/a
Pretax Income	-309.54M	-318.16M	-314.25M	-274.87M	29.4M	-84.13M	-102.56M	-92.19M	-74.38M
Net Income	-309.85M	-306.74M	-296.93M	-181.22M	29.4M	-77.82M	-102.56M	-92.19M	-74.38M
Selling & General & Admin	175.02M	169.82M	160.85M	124.12M	72.8M	75.49M	63.49M	59.12M	47.79M
Research & Development	134.92M	187.17M	193M	112.9M	64.15M	59.63M	62.59M	65.32M	67.62M
Other Expenses	83.72M	30.26M	7.64M	93K	2.06M	1.02M	848K	516K	103K
Operating Expenses	393.66M	387.25M	353.85M	237.02M	136.95M	135.12M	126.08M	124.44M	115.4M
Interest Expense	13.41M	14.34M	14.69M	12.53M	267K	2.61M	2.42M	2.92M	3.23M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	510.39M	534.99M	433.12M	308.68M	183.28M	191.44M	179.61M	183.25M	161.96M
Income Tax Expense	316K	-11.42M	-17.32M	-93.65M	-6.98M	-6.32M	848K	-5M	3.34M
Shares Outstanding (Basic)	274.49M	253.63M	224.46M	203.62M	172.96M	152.53M	134.95M	105.68M	89.15M
Shares Outstanding (Diluted)	288.37M	253.63M	224.55M	204.14M	174.97M	152.53M	135.09M	105.68M	89.15M
EPS (Basic)	-1.12	-1.21	-1.32	-0.89	0.18	-0.51	-0.76	-0.87	-0.83
EPS (Diluted)	-1.07	-1.21	-1.32	-0.89	0.17	-0.51	-0.76	-0.87	-0.83
EBITDA	-356.38M	-277.28M	-282.24M	-250.76M	38.97M	-71.58M	-92.92M	-80.83M	-67.27M
EBIT	-296.12M	-303.82M	-299.56M	-262.34M	29.67M	-81.52M	-100.14M	-89.27M	-71.14M
Depreciation & Amortization	53.35M	26.53M	17.32M	11.59M	9.3M	9.95M	7.21M	8.44M	3.88M